Resolving Chronic Neck Pain with Intra-Annular Fibrin Injection: How a Mid-Career Software Engineer Avoided Cervical Fusion
A 47-year-old software engineer with three years of progressive neck pain, cervicogenic headaches, and right-arm paresthesia traced to a C6-C7 annular tear avoided cervical fusion surgery through intra-annular fibrin injection at ValorSpine. Within 26 weeks he returned to full desk-based work, resumed strength training, and reduced VAS pain from 7.8 to 2.1 cm without fusion hardware or adjacent segment risk.
Case Snapshot
- Patient: Anonymized. 47-year-old male software engineer, sedentary occupation, recreational lifter.
- Primary diagnosis: Right C7 cervical radiculopathy secondary to a contained C6-C7 posterolateral annular tear with discogenic pain.
- Symptom duration before treatment: Approximately 38 months of progressive symptoms.
- Failed prior treatments: Physical therapy, NSAIDs, gabapentin, two cervical epidural steroid injections, ergonomic restructuring.
- Surgical recommendation declined: Anterior cervical discectomy and fusion (ACDF) at C6-C7.
- Approach: Single-session intra-annular fibrin injection at C6-C7 under fluoroscopic guidance, followed by structured cervical rehabilitation.
- Primary outcomes at 26 weeks: VAS pain 7.8 cm to 2.1 cm; Neck Disability Index 38 to 8; full return to work; resumption of barbell training.
This case study is part of our cervical-focused series under the forthcoming Cervical Spine and Neck Pain pillar and complements the broader cluster on spinal fusion alternatives. The patient described here came to ValorSpine after being told that anterior cervical discectomy and fusion was his next reasonable step. He left fusion-free, with documented disc-level repair and a measurable functional recovery. The pattern reinforces what published cohort data on intra-annular fibrin injection has shown for lumbar discs and what we are increasingly seeing in cervical cases: a torn but contained disc can be sealed and biologically stabilized rather than removed.
Readers researching their own options may also find it useful to evaluate spine treatment options before committing to surgery and to talk to a surgeon about non-surgical options as part of an informed decision.
Context and Baseline
The patient is a 47-year-old senior software engineer who spends an average of 9 to 11 hours per day at a multi-monitor workstation. He is right-hand dominant and reports no prior cervical trauma other than a low-speed rear-end collision approximately five years before symptom onset, after which he was symptom-free for roughly 18 months. He is a non-smoker with a normal body mass index, no diabetes, and no history of inflammatory arthropathy.
His symptoms began as posterior neck stiffness that he initially attributed to long coding sessions. Over the next 18 months, the pain spread to the right trapezius and scapular border, then evolved into intermittent burning and electric sensations radiating into the right lateral forearm and the index and middle fingers. By month 30 he was waking two to four times per night because of pain. He described worsening with sustained looking-down posture, prolonged driving, and overhead reaching.
Cervical MRI at presentation demonstrated multilevel mild degenerative change with a focal posterolateral annular fissure and a small contained protrusion at C6-C7 contacting the right C7 nerve root. C5-C6 showed mild disc desiccation without significant protrusion. Disc heights were preserved, and there was no instability on flexion-extension imaging. Electrodiagnostic testing demonstrated a chronic, non-active right C7 radiculopathy without denervation in the corresponding myotome.
Standardized intake measurements at his first ValorSpine consultation:
- VAS neck pain (current): 7.8 cm
- VAS arm pain (current): 6.4 cm
- Neck Disability Index: 38 (severe disability range)
- PROMIS Pain Interference T-score: 67
- Cervicogenic headache frequency: 4 to 5 days per week
- Sleep disruption: 2 to 4 awakenings per night
- Work productivity: Self-reported reduction of approximately 30 percent due to pain and concentration loss
His clinical picture matched a discogenic, mechanically loaded cervical pain pattern with a structurally identifiable annular lesion. He was not a candidate for total disc replacement because of his preserved disc height and contained morphology, and he was strongly motivated to avoid both fusion and the adjacent segment problem associated with it. Roughly 40 percent of back surgeries do not achieve the patient’s desired outcome, and revision surgery rates can exceed 20 percent within 10 years; he had read both figures before he arrived.
Why a Non-Surgical, Disc-Repair Approach Was Considered
Three considerations shaped the recommendation:
1. The lesion was contained and structurally repairable. The MRI did not show extruded disc material or sequestration. The C7 nerve root contact was from a small protrusion at the site of the annular tear, not from a free fragment. That morphology is the type of lesion biologic disc repair is designed to address: seal the annular defect, reduce nuclear extravasation and chemical irritation, and let the segment behave more like a non-painful disc.
2. He had failed appropriate conservative care. He had completed two distinct courses of physical therapy totaling more than 30 sessions, used NSAIDs and gabapentin without durable benefit, and obtained only two to four weeks of relief from each of two cervical epidural steroid injections. The AAFP systematic review on epidural steroid injections found them not effective for chronic low back pain alone, and his cervical experience mirrored that: short-term flare control without disease modification.
3. The fusion alternative carried structural costs he wanted to avoid. ACDF at C6-C7 would have eliminated motion at the most mobile lower cervical segment in a patient with a 20-plus-year work horizon at a desk. Adjacent segment disease following cervical fusion is a recognized concern, and average recovery from fusion procedures is 3 to 6 months or longer. He explicitly raised both points during consultation.
Patients in similar positions often find it helpful to first review whether they meet candidacy criteria for fusion and to compare fibrin disc treatment versus fusion directly.
Approach
The treatment plan had three phases: confirm the lesion under live imaging, deliver intra-annular fibrin to the targeted defect, and then rebuild cervical capacity with a structured rehabilitation protocol.
Diagnostic confirmation
Before treatment, the patient underwent provocation testing under fluoroscopy to confirm that the C6-C7 disc was the dominant pain generator. Reproduction of his concordant neck and right-arm symptoms with the targeted disc, and absence of concordant symptoms at adjacent levels, supported single-level intervention. C5-C6 was assessed and not treated.
Intra-annular fibrin injection
The procedure was performed in a fluoroscopy suite under local anesthesia and light sedation. Using a posterolateral approach guided by real-time imaging, a fine-gauge needle was advanced into the C6-C7 disc and positioned at the posterolateral annular fissure identified on MRI. After confirming intradiscal placement with a small contrast injection that demonstrated the fissure, fibrin sealant was delivered into the annular defect. The fibrin acts as a scaffold within the torn fibers and supports the disc’s own repair response. Total intradiscal time was under five minutes; total table time was approximately 45 minutes.
Post-procedure protocol
- Weeks 0 to 2: Relative rest. Soft cervical collar for activity only, not for sleep. No lifting greater than 5 kg. Walking encouraged. Workstation use limited to 4 hours per day with hourly breaks.
- Weeks 3 to 6: Initiation of cervical rehabilitation focused on deep neck flexor activation, scapular stabilization, and thoracic mobility. Gradual return to full workday with ergonomic adjustments.
- Weeks 7 to 12: Progressive loading. Reintroduction of compound resistance training under supervision, beginning with neutral-spine pulling and pressing patterns. Avoidance of cervical end-range loading.
- Weeks 13 to 26: Maintenance phase. Independent strength program, daily mobility, and monitoring of symptom recurrence triggers.
Implementation Timeline
| Phase | Weeks | Clinical Focus | Patient Activity |
|---|---|---|---|
| Pre-procedure workup | -2 to 0 | MRI review, EMG, provocation assessment | Standardized PROMs collected |
| Procedure day | 0 | Fluoroscopic intra-annular fibrin injection at C6-C7 | Same-day discharge |
| Early healing | 1 to 2 | Inflammation control, monitoring | Restricted activity, walking |
| Guided rehab | 3 to 6 | Deep neck flexor, scapular stability | Return to limited desk work |
| Progressive loading | 7 to 12 | Strength reintroduction | Full work hours, supervised lifting |
| Maintenance | 13 to 26 | Independent program, outcome review | Full training, full work |
Results
Outcome measures were collected at baseline, 6 weeks, 12 weeks, and 26 weeks. The trajectory was steady rather than dramatic, with most of the symptom reduction occurring between weeks 6 and 16 as the disc-level changes consolidated and rehabilitation capacity increased.
| Measure | Baseline | Week 6 | Week 12 | Week 26 |
|---|---|---|---|---|
| VAS neck pain (cm) | 7.8 | 5.2 | 3.4 | 2.1 |
| VAS arm pain (cm) | 6.4 | 3.1 | 1.2 | 0.4 |
| Neck Disability Index | 38 | 24 | 14 | 8 |
| PROMIS Pain Interference T | 67 | 58 | 52 | 47 |
| Cervicogenic headaches per week | 4-5 | 2-3 | 1 | 0-1 |
| Nightly sleep awakenings | 2-4 | 1-2 | 0-1 | 0 |
| Work hours tolerated | ~5.5 | 6 | 8 | 9-10 |
Functional milestones included return to a full eight-hour workday at week 12, resumption of supervised barbell training at week 14, and a self-reported return to pre-symptom productivity by week 22. The right-arm paresthesia, which had been the patient’s most distressing complaint, was the symptom that resolved most completely.
These outcomes are consistent with the broader pattern reported in published cohort data on intra-annular fibrin injection: VAS pain scores in fibrin studies have been reported to drop from 72.4 mm at baseline to 33.0 mm at 104 weeks, with around 70 percent patient satisfaction at 2-plus year follow-up. Individual results vary, particularly with cervical anatomy and lesion characteristics, and this single case is presented as a case study, not as proof of population-level effect.
Lessons Learned
1. The annular tear, not the degenerative changes overall, is the right target. The patient had multilevel degeneration on imaging. Treating C5-C6 prophylactically would have been overreach. Selecting a single concordant level under provocation testing kept the procedure focused and made the outcome interpretable.
2. Rehabilitation is not optional. Fibrin disc treatment seals the lesion; rehabilitation rebuilds the cervical system that allowed the lesion to develop. Without the deep neck flexor and scapular stabilization work, the same posture-loaded environment that produced the C6-C7 tear would have remained unchanged. The structured, phased return to load was as important to the 26-week outcome as the procedure itself.
3. Steroid response history is informative but not predictive. The patient’s two prior cervical epidural steroid injections produced only short-term relief. That pattern was useful for clarifying that the pain was driven by ongoing structural irritation rather than a transient inflammatory event, which strengthened the rationale for biologic repair. It did not predict whether fibrin would help; the structural lesion did.
4. Patient time horizon matters. Avoiding fusion in a 47-year-old with two decades of desk work ahead is a different calculus than in a 75-year-old with a focal collapse. Adjacent segment disease and revision surgery probabilities compound over years. The longer the time horizon, the higher the value of preserving native motion segments.
5. Recovery felt slow at week four. Patient-reported expectation mismatch was the main coaching challenge between weeks 2 and 6. Biologic healing is gradual, and the most meaningful gains occurred after week 6. Setting that expectation in writing at intake reduced anxiety in the early healing window.
For readers earlier in their decision process, our resources on how to prepare for a spine alternatives consultation and the spine treatment recovery FAQ describe the same protocol structure used in this case.
Transparency: What We Would Do Differently
Two elements of this case would change in future similar patients:
- Earlier ergonomic assessment. The patient had already restructured his workstation before he reached us, but a formal cervical-loading audit at week 0 rather than week 4 would have shortened the relapse-risk window during early healing.
- More granular outcome capture between weeks 2 and 6. The standard 6-week interval missed the inflection point where his sleep first improved, which would be a useful early indicator of response. Future patients receive a brief weekly check-in during that window.
It is also worth being explicit about what this case does not establish. It is one cervical case in a single patient with a contained posterolateral annular fissure, preserved disc height, and high motivation for non-surgical management. It does not establish efficacy in central cervical stenosis, large extruded fragments, multilevel concordant pain, or progressive myelopathy. Patients with those presentations may not be candidates for biologic disc repair and may need a different pathway. We document declined and unsuitable cases as carefully as successful ones.
Frequently Asked Questions
Is intra-annular fibrin injection considered surgery?
No. Intra-annular fibrin injection is a minimally invasive, image-guided procedure performed through a fine needle under fluoroscopy. It does not involve incision of the disc, removal of disc material, or hardware placement. Same-day discharge is standard.
How is this different from a cervical epidural steroid injection?
A cervical epidural steroid injection delivers anti-inflammatory medication into the epidural space surrounding the nerve root and is intended to reduce inflammation. Intra-annular fibrin injection delivers a biologic sealant into the torn annular fibers of the disc itself and is intended to support structural repair of the lesion. The targets, mechanisms, and goals are different.
Who is not a candidate for cervical fibrin disc treatment?
Patients with large extruded or sequestered disc fragments, significant central canal stenosis, progressive myelopathy, segmental instability, or active infection are generally not candidates. Multilevel concordant pain without a dominant lesion is also a contraindication for single-level treatment.
How long until a patient can return to desk work?
In this case, restricted desk work resumed within two weeks and full eight-hour days resumed by week 12. Return-to-work timelines vary with occupation, ergonomic environment, and rehabilitation adherence.
Does this procedure prevent the need for fusion forever?
No. Biologic disc repair addresses the current annular lesion and discogenic pain pattern. It does not stop future degenerative change at other levels. Patients still need ongoing cervical care, posture management, and strength maintenance. In appropriately selected patients, however, it can defer or replace the immediate fusion recommendation.
How does this approach compare with cervical disc replacement?
Cervical disc replacement removes the native disc and installs a motion-preserving implant. Intra-annular fibrin injection preserves the native disc and supports its repair. Disc replacement is a structural alternative to fusion; fibrin treatment is a biologic alternative that aims to avoid both.
Sources and Further Reading
- American Academy of Family Physicians (AAFP) – systematic review on epidural steroid injections for chronic low back pain.
- Peer-reviewed clinical literature on intra-annular fibrin injection – VAS and patient satisfaction outcomes at 2-plus year follow-up.
- Journal of Neurosurgery – cervical fusion outcome and adjacent segment disease data.
- National Institute of Neurological Disorders and Stroke (NINDS) – cervical radiculopathy clinical overview.
- Published cohort data on conservative management of cervical radiculopathy – natural history and treatment failure rates.
Ready to Explore Non-Surgical Options?
Ready to explore non-surgical options for your back pain? Schedule your consultation with ValorSpine today. If you are weighing fusion against biologic disc repair, our team will review your imaging, your history, and your goals before recommending a path. For broader context, see our 7 best spinal fusion alternatives, our guidance on how to avoid spinal fusion surgery, our comparison of non-surgical spine treatments, our cost and insurance FAQ, our alternatives options FAQ, and related cases including the adjacent segment disease fibrin case study, the veteran annular tear case study, and the failed back surgery case study.
